Resultados da pesquisa - Jan Šperl
- A mostrar 1 - 9 resultados de 9
-
1
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia Por Stefan Zeuzem, Marı́a Buti, Peter Ferenci, Jan Šperl, Yves Horsmans, Janusz Cianciara, E Ibrányi, Ola Weiland, Stephanie Noviello, Clifford A. Brass, Janice K. Albrecht
Publicado em 2005Artigo -
2
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure Por Rajeshwar P. Mookerjee, Marco Pavesi, Karen Louise Thomsen, Gautam Mehta, Jane Macnaughtan, Flemming Bendtsen, Minneke J. Coenraad, Jan Šperl, Pere Ginès, Richard Moreau, Vicente Arroyo, Rajiv Jalan
Publicado em 2015Artigo -
3
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load Por Stuart C. Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Jan Šperl, Phillip Dinh, Eduardo B. Martins, Leland J. Yee, John F. Flaherty, Kathryn M. Kitrinos, Vinod K. Rustgi, Patrick Marcellin
Publicado em 2013Artigo -
4
Severe alpha-1 antitrypsin deficiency shows a higher risk of complications after first decompensation compared to other aetiologies of cirrhosis☆ Por Lorenz Balcar, Malin Fromme, Naomi Kappe, Benedikt Schaefer, Soňa Fraňková, Lukas Van Melkebeke, Jan Stolk, Mathias Jachs, Georg Semmler, Benedikt Hofer, Tammo Lambert Tergast, Hannah Rieland, Anna Sophie Karl, Jan Šperl, Martin Wagner, Mònica Pons, Harald Hofer, Markus Peck‐Radosavljevic, Michael Trauner, Thomas Reiberger, Benjamin Maasoumy, Heinz Zoller, Bart van Hoek, Jef Verbeek, Pavel Strnad, Mattias Mandorfer
Publicado em 2025Artigo -
5
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe Por Alison D. Marshall, Evan B. Cunningham, Stine Nielsen, Alessio Aghemo, Hannu Alho, Markus Backmund, Philip Bruggmann, Olav Dalgård, Carole Seguin‐Devaux, Robert Flisiak, Graham R. Foster, Liana Gheorghe, David Goldberg, Ioannis Goulis, Matthew Hickman, Patrick Hoffmann, Ligita Jančorienė, Peter Jarčuška, Martin Kåberg, Leondios G. Kostrikis, Mihály Makara, Matti Maimets, Rui Tato Marinho, Mojca Matičič, Suzanne Norris, Sigurður Ólafsson, Anne Øvrehus, Jean‐Michel Pawlotsky, James Pocock, Geert Robaeys, Carlos Roncero, Marieta Simonova, Jan Šperl, Michele Tait, Ieva Tolmane, Stefan Tomaselli, Marc van der Valk, Adriana Vince, Gregory J. Dore, Jeffrey V. Lazarus, Jason Grebely
Publicado em 2017Artigo -
6
Longitudinal evaluation of individuals with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype) Por Malin Fromme, Audrey Payancé, Mattias Mandorfer, Katrine Holtz Thorhauge, Mònica Pons, Marc Miravitlles, Jan Stolk, Bart van Hoek, Guido Stirnimann, Soňa Fraňková, Jan Šperl, Andreas E. Kremer, Barbara Burbaum, Christina Schrader, Amine Kadioglu, Michelle Walkenhaus, Carolin V. Schneider, Fabienne Klebingat, Lorenz Balcar, Naomi Kappe, Benedikt Schaefer, Joanna Chorostowska-Wynimko, Elmar Aigner, Sophie Gensluckner, Philipp Striedl, Pascal Roger, John Ryan, Suzanne Roche, Marius Vögelin, Aftab Ala, Heike Bantel, Jef Verbeek, Zoe Mariñó, Michael Praktiknjo, Tom J.G. Gevers, Philipp Reuken, Thomas Berg, Jacob George, Münevver Demir, Tony Bruns, Christian Trautwein, Heinz Zoller, Michael Trauner, Joan Genescà, William J. Griffiths, Virginia Clark, Aleksander Krag, Alice Turner, Noel G. McElvaney, Pavel Strnad
Publicado em 2024Artigo -
7
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Por Homie Razavi, Imam Waked, Christoph Sarrazin, Robert P. Myers, Ramazan İdilman, Filipe Calinas, W. Vogel, Maria Cássia Mendes Corrêa, Christophe Hézode, Pablo Lázaro, Ulus Salih Akarca, Soo Aleman, İsmail Balık, Thomas Berg, Florian Bihl, Marc Bilodeau, Antonio Javier Blasco, Carlos Eduardo Brandão‐Mello, Philip Bruggmann, Marı́a Buti, José Luís Calleja, Hugo Cheinquer, Peer Brehm Christensen, Mette Rye Clausen, Henrique Sergio Coelho, Matthew Cramp, G.J. Dore, W. Doss, Ann‐Sofi Duberg, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Karolin Falconer, J Félix, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Soňa Fraňková, Javier García‐Samaniego, Jan Gerstoft, José Gíria, Fernando Lopes Gonçales, E. Gower, Michael Gschwantler, Mário G. Pessôa, S. J. Hindman, Heribert Hofer, Petr Husa, Martin Kåberg, Kelly Kaita, Achim Kautz, Sabahattin Kaymakoğlu, Mel Krajden, Henrik Krarup, Wim Laleman, Daniel Lavanchy, Rui Tato Marinho, Paul Marotta, Stefan Mauss, Christophe Moreno, K. Murphy, Francesco Negro, Vratislav Němeček, Necati Örmecı, Anne Øvrehus, Julie Parkes, K. Pasini, Kevork Peltekian, Alnoor Ramji, Nathalia Rodrigues dos Reis, S. Roberts, William Rosenberg, Françoise Roudot‐Thoraval, Stephen Ryder, Rui Sarmento‐Castro, David Semela, Morris Sherman, Gamal Shiha, William Sievert, Jan Šperl, Peter Stärkel, R.E. Stauber, A. Thompson, Petr Urbánek, Pierre Van Damme, Ingo van Thiel, Hans Van Vlierberghe, Dominique Vandijck, Heiner Wedemeyer, Nina Weis, Johannes Wiegand, A. Yosry, Amany Zekry, Markus Cornberg, Beat Müllhaupt, Chris Estes
Publicado em 2014Artigo -
8
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in selected countries Por Philip Bruggmann, Thomas Berg, Anne Øvrehus, Christophe Moreno, Carlos Eduardo Brandão‐Mello, Françoise Roudot‐Thoraval, Rui Tato Marinho, Morris Sherman, Stephen Ryder, Jan Šperl, Ulus Salih Akarca, İsmail Balık, Florian Bihl, Marc Bilodeau, Antonio Javier Blasco, Marı́a Buti, Filipe Calinas, José Luís Calleja, Hugo Cheinquer, Peer Brehm Christensen, Mette Rye Clausen, Henrique Sergio Coelho, Markus Cornberg, Matthew Cramp, Gregory J. Dore, Wahid Doss, Ann‐Sofi Duberg, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Chris Estes, Karolin Falconer, J Félix, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Soňa Fraňková, Javier García‐Samaniego, Jan Gerstoft, José Gíria, Fernando Lopes Gonçales, E. Gower, Michael Gschwantler, Mário G. Pessôa, Christophe Hézode, Heribert Hofer, Petr Husa, Ramazan İdilman, Martin Kåberg, K. Kaita, Achim Kautz, Sabahattin Kaymakoğlu, Mel Krajden, Henrik Krarup, Wim Laleman, Daniel Lavanchy, Pablo Lázaro, Paul Marotta, Stefan Mauss, Maria Cássia Mendes Corrêa, Beat Müllhaupt, Robert P. Myers, Francesco Negro, Vratislav Němeček, Necati Örmecı, Julie Parkes, Kevork Peltekian, Alnoor Ramji, Homie Razavi, Nathalia Rodrigues dos Reis, Stuart K. Roberts, William Rosenberg, Rui Sarmento‐Castro, C. Sarrazin, David Semela, Gamal Shiha, William Sievert, Peter Stärkel, Rudolf Stauber, A. Thompson, Petr Urbánek, Ingo van Thiel, Hans Van Vlierberghe, Dominique Vandijck, W. Vogel, Imam Waked, Heiner Wedemeyer, Nina Weis, Johannes Wiegand, A. Yosry, Amany Zekry, Pierre Van Damme, Soo Aleman, S. J. Hindman
Publicado em 2014Revisão -
9
Strategies to manage hepatitis <scp>C</scp> virus (<scp>HCV</scp>) disease burden Por Heiner Wedemeyer, A.‐S. Duberg, Marı́a Buti, William Rosenberg, Soňa Fraňková, Gamal Esmat, Necati Örmecı, Hans Van Vlierberghe, Michael Gschwantler, Ulus Salih Akarca, Soo Aleman, İsmail Balık, Thomas Berg, Florian Bihl, Marc Bilodeau, Antonio Javier Blasco, Carlos Eduardo Brandão‐Mello, Philip Bruggmann, Filipe Calinas, José Luís Calleja, Hugo Cheinquer, Peer Brehm Christensen, Mette Rye Clausen, Henrique Sérgio Moraes Coelho, Markus Cornberg, Matthew Cramp, Gregory J. Dore, Wahid Doss, Manal H. El‐Sayed, Gül Ergör, Chris Estes, Karolin Falconer, J Félix, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Javier García‐Samaniego, Jan Gerstoft, José Gíria, Fernando Lopes Gonçales, Mário G. Pessôa, Christophe Hézode, S. J. Hindman, Heribert Hofer, Petr Husa, Ramazan İdilman, Martin Kåberg, Kelly Kaita, Achim Kautz, Sabahattin Kaymakoğlu, Mel Krajden, Henrik Krarup, Wim Laleman, Daniel Lavanchy, Pablo Lázaro, Rui Tato Marinho, Paul Marotta, Stefan Mauss, Maria Cássia Mendes Corrêa, Christophe Moreno, Beat Müllhaupt, Robert P. Myers, Vratislav Němeček, Anne Øvrehus, Julie Parkes, Kevork Peltekian, Alnoor Ramji, Homie Razavi, Nathalia Rodrigues dos Reis, Stuart K. Roberts, Françoise Roudot‐Thoraval, Stephen Ryder, Rui Sarmento‐Castro, Christoph Sarrazin, David Semela, Morris Sherman, Gamal Shiha, Jan Šperl, Peter Stärkel, Rudolf Stauber, A. Thompson, Petr Urbánek, Pierre Van Damme, Ingo van Thiel, Dominique Vandijck, W. Vogel, Imam Waked, Nina Weis, Johannes Wiegand, A. Yosry, Amany Zekry, Francesco Negro, William Sievert, E. Gower
Publicado em 2014Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Virus
Gastroenterology
Hepatitis C virus
Hepatitis C
Virology
Immunology
Viral load
Alpha (finance)
Alpha 1-antitrypsin deficiency
Construct validity
Disease
Disease burden
Environmental health
Intensive care medicine
Ribavirin
Viremia
Adefovir
Alpha interferon
Antiretroviral therapy
BETA (programming language)
Biochemistry
Biology
Burden of disease
Business
Cardiology
Cirrhosis
Clinical psychology
Combination therapy